Trial intelligence / Profile preview

Limaprost for Cervical Myelopathy Post-Surgery

NCT02125981Phase 3Completed

Sponsor
Seoul National University Hospital
Start
Sep 2014
Primary completion
Oct 2022
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of limaprost in cervical myelopathy, sponsored by Seoul National University Hospital. Started Sep 2014; status: completed.

02

Drugs

limaprost
03

Conditions

cervical myelopathy

Beyond the preview

Go deeper on NCT02125981.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02125981.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call